Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 10, 2023

Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 10, 2023

Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 10, 2023

Our first Tuesday session of 2023. Happy New Year to all … may it be healthy!

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/

Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Join our other free and drop in groups:
Men (Only) Speaking Freely …1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare … 4th Thursday @ 8.00 pm Eastern https://ancan.org/veterans/

Editor’s pick: A spectrum of therapies (proton beam, BAT, CAR-T, PARPi, Pluvicto) plus unanswered questions on the connections between PSA, PSMA, and CT scans. (bn)

Topics Discussed

Will proton radiation spare his colitis (aggravated by transrectal biopsy)…or make it worse?; cystitis 18 months after radiation leads to surgery and a prescription for hyperbaric oxygen — how safe?; testing after surgery shows new lesions and doubled PSA; can undetectable PSA with known mets still yield a meaningful PSMA PET?; will finding from ARCHES study persuade doc who rejects anatomical scan?; to fix low iron, stop taking so much; happy to see a lung lesion disappear; 8 days into BAT (and insurance approved it!); back surgery for Prof. Herb’s pain; no-chemo-required trial for Pluvicto; CAR-T a strong possibility as he runs low on options; platelets crashing — why so much chemo?; is “node-only” local or widespread?; good lab news on a birthday; PARP inhibitors without a mutation; preparing for scans as his low PSA moves the needle.

Chat Log

Unknown · 6:16 PM First Tuesday meeting. First meeting of year on 1/2/23

AnCan – rick · 6:34 PM George – here’s the http://prostatecancerinfolink.net/2012/02/01/first-directly-comparative-data-question-safety-of-pbrt-vs-imrt/

AnCan – rick · 6:36 PM Peter – can you see the hands up?

Peter Kafka-Maui, HI · 6:37 PM i cant see raised hands

John A · 6:38 PM it’s Jim Marshall with the raised hand

George Southiere · 6:38 PM can see them

Richard Wassersug · 6:42 PM I just looked in PubMed on “colitis” “proton beam therapy” and “prostate cancer”. Nothing came up. So no evidence that PBT is better or worse for colitis.

AnCan – rick · 6:47 PM @Richard – have you read the article I posted? I believe it suggests that GI side effects are worse with Proton. Not specifically related to colitis.

AnCan – rick · 6:49 PM Here’s the PROMISE trial link, George – free germline/inherited genetic tested. https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar

David Muslin · 6:49 PM What kind of suppositiry did he say he was taking?

AnCan Herb · 6:50 PM I thought sucralfate

Richard Wassersug · 6:53 PM RD,

Richard Wassersug · 6:53 PM Yes, I know the study.

AnCan – rick · 7:01 PM Dr. Sean Collins Rad Onc https://gufaculty360.georgetown.edu/s/contact/00336000014RVJeAAO/sean-collins

Pat Martin · 7:04 PM Sorry to have to leave. I’ll be back next week

Richard Wassersug · 7:07 PM I just checked on PubMed and found a couple of papers reporting several features of the visual system that are at heighten risk of oxidative injury with extensive hyperbaric oxygen exposure. But I only scanned the abstracts and I don’t know how high the risk actually is. At least we now know that there is published research on this topic!

John A · 7:24 PM https://dailynews.ascopubs.org/do/arches-analysis-underscores-importance-regular-imaging-detect-progression-patients

John A · 7:26 PM ARTICLE CITATION DOI: 10.1200/JCO.19.00799 Journal of Clinical Oncology 37, no. 32 (November 10, 2019) 2974-2986. Published online July 22, 2019. PMID: 31329516

George Southiere · 7:26 PM sorry I have to go guys, Im very tired, started PT for my back and doing aquatherapy

George Southiere · 7:26 PM goodnight

AnCan – rick · 7:27 PM Long term ADT!!!!

Richard Wassersug · 7:29 PM Got to good. Thanks all for letting me occasionally join this group.

George Wesoloski · 7:32 PM What is “bat”?

Alan Babcock · 7:33 PM I have to go. My wife is sick. Next week.

Rich Jackson · 7:38 PM https://clinicaltrials.gov/ct2/show/NCT04720157

Tonyfig · 7:43 PM There has been some studies about iron’s role with cancer. Here is a Pubmed article . https://pubmed.ncbi.nlm.nih.gov/30130469/. Tumour cells and bacteria need iron to grow, and your body tries to starve them of iron by diverting the iron from the blood to storage sites deep within the tissues. It is well known, biochemically, that if you add iron to tumour cells in cultures, they grow at a much faster rate and that breast cancer cells thrive on iron. In 1988, many studies began to surface showing that iron was indeed a risk in common cancers such as lung, colon, bladder, oesophagus, and at levels that were shockingly less than doctors had previously considered dangerous. A study in the New England Journal of Medicine (Oct 1988) by Dr Richard Stevens showed that as iron saturation levels increase, cancer rates go up. Until that time a 65% of saturation level was considered to be safe, but this study showed that at a 37% saturation level, the cancer rate started to skyrocket, and doctors began to question the levels they had previously considered safe. In January 1944, in the International Journal of Cancer, Dr Stevens reported that cancer rates were increasing at levels of only 31%.

Mark Finn · 8:01 PM Protocol number – IRB21-0411. Sponsored by Bellicum.

Joe Gallo · 8:03 PM Sorry to be late

Frank Fabish Columbus OH · 8:04 PM Got to go guys. Happy new year to all. Stay healthy.

Joe Gallo · 8:05 PM Sorry they didn’t show. I had someone over at CSC who need help

 

FDA Approves Briumvi (Ublituximab) for Relapsing Multiple Sclerosis

FDA Approves Briumvi (Ublituximab) for Relapsing Multiple Sclerosis

FDA Approves Briumvi (Ublituximab) for Relapsing Multiple Sclerosis

briumvi, msIn case you haven’t heard the news by now, the FDA recently approved Briumvi (Ublituximab), by TG Therapeutics, for the treatment of relapsing-remitting Multiple Sclerosis.

The drug is now the 3rd CD20 anti-b-cell therapy on the market for Multiple Sclerosis. Up until now, Ocrevus (ocrelizumab) and Kesimpta (ofatumumab) were the only B-cell targeting drugs available on the market.

This is great news, because B-cell therapies, such as the drugs named above, have all been proven highly effective as disease-modifying therapies for MS.

Given as a twice-yearly infusion, Briumvi is currently available for Relapsing-remitting MS (RRMS), Clinically-Isolated Syndrome (CIS), and Secondary-progressive MS (SPMS).

According to the MS News Today article below, “Briumvi was engineered to be more potent than other anti-CD20 therapies, allowing for lower doses and shorter infusion times.”

Read more about it here, on Multiple Sclerosis News Today

MS is a disease of the central nervous system that specifically targets the myelin sheath in the brain and spinal cord. Any time those with MS can get a new medication available to them on the market, it’s a huge victory in the fight against a disease that can take away almost every function in the human body.

If you’re one of us in the MS “club”, join us every 2nd and 4th Tuesdays of the month for our MS group meeting here

 

 

Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 10, 2023

Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 2, 2023

Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 2, 2023

 

Happy New Year to all … may it be healthy!

Please consider a donation based on the support you’ve gotten from these recordings in 2022. Read our letter at https://us14.admin.mailchimp.com/camp…

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Join our other free and drop in groups: Men (Only) Speaking Freely …1st & 3rd Thursdays @ 8.00 pm Eastern https://www.gotomeet.me/AnswerCancer       Veterans Healthcare … 4th Thursday @ 8.00 pm Eastern https://www.gotomeet.me/AnswerCancer

Editor’s Pick: Is AnCan onto yet another largely unreported side effect – Pluvicto & myopathy (muscle wasting)? And 20% of mHSPC men show progression w/o PSA rise (ARCHES trial)!!  (rd)

Topics Discussed

Brainstorming hot flashes – from acupuncture to Megace; pain management; Pluvicto and myopathy; Pluvicto availability poses tx dilemma; more pain management re. Pluvicto; logistics of a Pluvicto session; urine stream and advanced PCa; upcoming Sholz webinar; better evidence from testicular PCa Mx could offer next tx guidance; sleep apnea; Payer attitude to repeat PSMA scans; what sequencing, PSMA and pathology offer; 20% of men on LHRH don’t show PSA rise with radiographic progression (see Len’s Chat post below); next step – BAT

Chat Log

Jim B · 8:17 PM Hi Bob, I am feeling pretty good all around. Finally I am in FL and getting settled in. On my first day here I was able to get a lot more exercise than up in the cold weather. How’s your WBC coming along?

Jimmy Greenfield · 8:26 PM BedJet3 Demo: https://youtu.be/t6i1j3tw8mQ

Peter Kafka – MAUI · 8:48 PM Organic dried prunes on a daily basis has helped me keep things moving. But strong drugs can be tough.

AnCan – rick · 9:13 PM Vets Group … https://ancan.org/veterans/

Paul Freda Lake Worth FL · 9:17 PM Where do we sign up for the Jan 30 Webinar ? Link ?

AnCan – rick · 9:20 PM Scholz webinar Scholz webinar https://attendee.gotowebinar.com/register/3476369222172706645

Bob G · 9:26 PM Testicular mets case study https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209256/#:~:text=Most%20secondary%20testicular%20metastases%20originate,for%20advanced%20disease%20%5B3%5D.

Phil Snyder (Houston) · 9:42 PM Have to leave Gentlemen, thanks for listening in on the interesting exchange.

Joel Blanchette Reston, VA · 9:44 PM I researched about 6 months ago and the Inspire cost $40,000

gary peters · 9:46 PM Yikes. No wonder they are trying to market the heck out of it. I would try a lot of masks before spending that.

Paul Freda Lake Worth FL · 9:49 PM https://www.easybreathe.com/Breathing-Machines/CPAPs-c832/

Joe Gallo · 9:49 PM Scholz webinar https://attendee.gotowebinar.com/register/3476369222172706645

gary peters · 9:56 PM LOL. I did not know that cost. Happy New Year

George Rovder, Arlington VA · 10:03 PM Inspire costs $1,400 with Medicare, according to Inspire website https://inspiresleep.com/ cost-and-eligibility

AnCan – rick · 10:06 PM @JeffW .. from Telix – “Medicare typically reimburses one scan for suspected metastases prior to definitive treatment, and scans after definitive treatment (biochemical recurrence) are not limited to a number, but all must meet medical necessity.   Commercial payors typically have similar policies, but there are so many different plans that the answer can vary. Almost all commercial payors require prior authorizations so the patient should know if the scan will be reimbursed before arriving for the test.”  Hope this helps.

Len Sierra · 10:08 PM Armstrong recommends imaging every 3 months in mHSPC. From the ASCO 2022 Annual Meeting: See yellow highlights below. https://dailynews.ascopubs.org/do/10.1200/ADN.22.200934/full/?cid=DM10522&bid=171588107    ARCHES Analysis Underscores Importance of Regular Imaging to Detect Progression in Patients With mHSPC Receiving Potent AR Inhibitors May 26, 2022   Dr. Andrew J. Armstrong Key Points: • Post hoc analysis of the ARCHES trial identified frequent discordance between radiographic progression and prostate-specific antigen (PSA) progression among patients with metastatic hormone-sensitive prostate cancer (mHSPC) receiving enzalutamide. • The results suggest that regular radiographic imaging, rather than serial PSA testing, is the preferred method for monitoring disease progression in patients with mHSPC receiving a potent androgen receptor inhibitor.

Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 10, 2023

Hi-Risk/Recurrent/Advanced PCa Video Chat, Dec 27, 2022

Hi-Risk/Recurrent/Advanced PCa Video Chat, Dec 27, 2022

Our only Fundraising Campaign of the year is winding up. All on the AnCan email distribution have been sent a request letter, which includes AnCan highlights from 2022. We ask you to consider a donation based on the support you’ve gotten from these recordings. Read our letter at https://us14.admin.mailchimp.com/campaigns/show?id=7976018

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/

Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Join our other free and drop in groups:
Men (Only) Speaking Freely …1st & 3rd Thursdays @ 8.00 pm Eastern https://www.gotomeet.me/AnswerCancer
Veterans Healthcare … 4th Thursday @ 8.00 pm Eastern https://www.gotomeet.me/AnswerCancer

Editor’s pick: Unintended consequence of radiation therapy — subsequent surgeries become risky. Plus: research into mushrooms — and a fanatic who had one of us chickening out and turning tail.

Topics Discussed

Patient who got radiation now needs organ repair after a damaging kidney stone treatment — but surgeon is pessimistic because of scarring, plus a bladder growth is discovered; kidney stone sufferers feel the pain; too many mushrooms — and do they even work?; turkey tail fanatic holds Dr. A hostage; hot-flash sufferer turns successfully to acupuncture; bowel problems after radiation; Gleason 9 with PSA of 1; beware colonoscopy if there’s bowel problems; old prostatectomy and new PSA rise; how high a PSA before salvage?; types of lung biopsy; cloak of secrecy getting yanked after he tells pharma reps of side effects; doc explains ADT duration for salvage; cancer patients OK with Medicare Advantage?; paying back to AnCan. (bn)

Chat Log

John A · 6:25 PM 75% are calcium

AnCan- rick · 6:31 PM Turkey Tail article …. Abrams http://www.cancernetwork.com/articles/expert-panel-reviews-strategies-nutrition-and-cancer-care

AnCan- rick · 6:33 PM Dr. E recording …. https://ancan.org/dr-e-on-the-patient-voice-and-thinking-outside-the-pill/

AnCan- rick · 6:37 PM White buttom mushies and PCa. http://prostatecancerinfolink.net/2015/10/01/
white-button-mushroom-powder-and-recurrent-prostate-cancer/#comment-165416
AnCan- rick · 6:43 PM Recent (2012) Developments in Mushroom Therapy http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339609/

AnCan- rick · 6:49 PM FDA approves turkey tail for certain cancer patients http://www.bastyr.edu/news/general-news/2012/11/
fda-approves-bastyr-turkey-tail-trial-cancer-patients
· 6:51 PM Host Defense Mushrooms. My Community: Comprehensive Immune Support. Buy on Amazon 120 Capsules

AnCan- rick · 6:53 PM FDA approves turkey tail for certain cancer patients … BAD LINK

Julian – Houston · 6:54 PM try this link https://bastyr.edu/about/news/fda-approves-bastyr-turkey-tail-trial-cancer-patients

AnCan- rick · 6:55 PM Tx Julian – mine should have read turkey tail trial !!!!

AnCan- rick · 7:22 PM Frank Fabish had the procedure Dr. Jack is discussing

Alan Babcock · 7:48 PM I am unable to raise my hand.

Pat Martin · 8:01 PM Have to run

Dr. E on the patient voice and thinking outside the pill

Dr. E on the patient voice and thinking outside the pill

Dr. E on the patient voice and thinking outside the pill

 

Dr. Eleni Efstathiou has a hypothetical question about your high-grade prostate cancer diagnosis that typifies her approach:  You alone can answer it, and you wonder why nobody asked you before.

The straight-talking Dr. E, an AnCan advisory board member and genitourinary oncology section chief at Houston Methodist, shared her views Monday night in a conversation with our High-Risk/Recurrent/Advanced prostate cancer group, which includes several of her patients.

Medicine needs to start thinking outside the pill, she said, tackling not only development of drugs but development of therapies. How should we be deploying drugs and other interventions? What timing, combinations, and sequences will achieve highest benefit and lowest toxicity?

One target for this rethinking is localized or locally advanced prostate cancer.  She’s gotten exceptional long-term results from more than two-thirds of patients by administering 3 to 6 months of ADT plus abiraterone, followed by prostatectomy.

Much of her philosophy is reflected in this work. First, therapeutic thinking led to strong results by putting drugs in a novel setting. Second, because 30% of patients don’t benefit from the treatment, biomarkers are needed to identify them and to develop treatments for them as well. Third, emphasis is needed on early-stage high-grade disease. Fourth, the patient gets a voice in whether to go forward.

She came to Monday’s meeting hoping to hear more of these voices. She asked what our own choices would be: Diagnosed with localized or locally advanced high-grade cancer, would we accept a prostatectomy in hopes of an excellent prognosis without further ADT?

Results were surprising. Half the men in the meeting still would decline the prostatectomy in favor of radiation and long-term hormones.  This opened a path for future discussion — what would make prostatectomy a stronger alternative?

In the 90-minute session, Dr. E also stressed the importance of using real-world evidence in addition to randomized clinical trials where results come slowly and have narrow applicability. She described the work leading to the development of second-generation antiandrogens.

And she hinted that groundbreaking news would be coming from the GU ASCO conference in February.

An edited transcript of the talk, with slides, is available.

Cancer Can Be a Glass Half Full!

Cancer Can Be a Glass Half Full!

Cancer Can Be a Glass Half Full!

Some of our Blog readers, have attended AnCan’s Speaking Freely virtual group. That’s our men-only meeting that talks about everything and anything EXCEPT treatment. It’s open to all men living with a chronic condition and provides a great opportunity twice a month to get things off your chest and to air issues where another perspective may help. Like all our meetings, it’s free and drop in on the 1st and 3rd Thursday of each month starting at 8.00 pm Eastern in our AnCan Barniskis Room.

Celebration of Alan Babcocks 17 years of service!, Penn State Harrisburg,  Morrison Gallery, Library Room 101, Middletown, December 9 2022 |  AllEvents.inDecember’s second meeting of the month hosted a newbie to Speaking Freely but not to our AnCan Groups. Alan Babcock has been attending our prostate cancer groups for a while; he was finally able to vacate his schedule to make a Speaking Freely group. Alan recently retired from a hugely meaningful and rewarding career where he supervised Disability Services for students at Penn State – Go Nittany Lions!! Over the years, his team enabled thousands of disabled students to graduate .

In the course of the SF group conversation, we spoke about how cancer has impacted our lives – positively and negatively. When Alan mentioned he’d be keeping track of all the gifts received from his prostate cancer experience, we immediately asked for a copy – and here it is.Thanks for sharing your vulnerabilities, Alan and for allowing others to learn and benefit!  (Editor: We’ve chosen to put Prostate in parenthesis, because for the large part, we think this applies to most all cancers!! )

Gifts of (Prostate) Cancer 

1. I experienced a flood of love and good wishes from family, friends, and colleagues.

2. I returned to therapy, and I deepened my self-understanding.

3. I had the opportunity to confront my mortality, which taught me to think about decisions I make day-to-day.

4. I saw my wife do battle with the medical establishment on my behalf and win.

5. My love for my wife deepened as we confronted a life crisis.

6. I watch myself travel from despair to acceptance. Once again, demonstrating my resilience to myself.

7. I was given the opportunity to learn how to love my wife in new ways.

8. For about the hundreth time, I saw my wife was a tower of strength, and I learned once again that she would always be there for me.

9. I felt my wife’s unconditional love as she held me while I cried for all of my losses.

10. I experienced what it was like to have somebody pray for me.

11. I took control of my well-being by firing my first urologist and finding better care elsewhere, which was empowering.

12. I talked to other men who had prostatectomies about highly personal subjects.

13. I started to learn how to engage in Mindfulness rather than just talking about it.

14. I experienced a high school friend showing how much he cared by not only investigating where I received treatment, but also the physician who was going to perform the prostatectomy.

15. My brother-in-law showed how much he cared by arranging a consultation with a physician at the Dana-Farber Cancer Center.

16. A professor, who I did not know well, gave me her telephone number, and told me to call any time day or night.

17. I learned what was helpful and what was unhelpful when someone was facing a life crisis.

18. I joined a support group, in which I learn much about prostate cancer and in which I receive support.

19. I am learning to accept my limitations.

20. I have helped other men, which has been rewarding

Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 10, 2023

Hi-Risk/Recurrent/Advanced PCa Video Chat, Dec 19, 2022

Hi-Risk/Recurrent/Advanced PCa Video Chat, Dec 19, 2022

Immediately preceding tonight’s meeting we also recorded a 90-minute discussion with one of AnCan’s favorite doctors, Eleni Efstathiou — Dr. E — worth watching! (https://youtu.be/-ssBargObwE).

Our one and only Fundraising Campaign of the year takes place this month. All on the AnCan distribution already received our ‘ask’ that also includes AnCan highlights from 2022. We ask you to consider a donation based on the support you’ve gotten from these recordings. Read our letter at https://us14.admin.mailchimp.com/campaigns/show?id=7976018

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/

Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Join our other free and drop in groups:
Men (Only) Speaking Freely …1st & 3rd Thursdays @ 8.00 pm Eastern https://www.gotomeet.me/AnswerCancer
Veterans Healthcare … 4th Thursday @ 8.00 pm Eastern https://www.gotomeet.me/AnswerCancer

Editor’s pick: Brokering a deal: C is ready to ditch his Embr Wave hot-flash device and P is searching for a bargain; the statins debate; many ideas on treating hip pain. (bn)

Topics Discussed

$200/hour interview available for castrate-resistant men; newcomer couple with lymph-node recurrence after prostatectomy; reminder of our caregiver and Speaking Freely groups; up-to-date treatment plan from a new radiation oncologist; good ADT response but hates hot flashes; hot flashes — what works, what doesn’t?; cutting a deal in used Embr Waves; the debate over statins; finally, the last Eligard shot; wealth of advice for hip pain that’s left doctors at a loss.

Chat Log

(Unknown) · 8:44 PM jturner@flinceresearch.com

Alan Babcock · 8:47 PM I am going to leave. Today is my son’s birthday and I want to call him.

Ben Nathanson · 9:03 PM “GU medical oncologist”
Ben Nathanson · 9:03 PM “genitourinary medical oncologist”

Frank Fabish · 9:10 PM Guys I got to go. That was a great session with Dr E. I hope she comes back.

Glenn · 9:14 PM Female children also should be tested in the case of specific genetic mutations

AnCan- rick · 9:15 PM Here’s the best link … https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar

Russ S., St. Paul · 9:18 PM I have a question about my husband’s NSE and Chromagin A test results when you have time

AnCan Herb · 9:24 PM Aravind Viswanathan, MD Provider in Lancaster, SC 803-285-4400
Specialties:Cancer – Prostate & Genitourinary, Urology

Joe Gallo · 9:42 PM Mark Moyad MD
Joe Gallo · 9:42 PM PCRI.org

AnCan Art Friends – December 15, 2022 – Birches & Birds

AnCan Art Friends – December 15, 2022 – Birches & Birds

Stressed? In pain? Take a break with us while we paint a relaxing winter scene with your peers who “get it”. While this is our last art class of 2022, we are coming back strong in 2023! (In fact, you can register here)

 

Supplies:

Acrylic paints: Blue / Purple / Yellow / White / Brown / Black / Red (or your choice bird color)

Brushes: Flat 3/4in OR similar size; Round size #8 or smaller

Canvas: 9in x 12in (or whatever size you want!)

Water / napkins / paper plate or palette

 

Watch here:

 

Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 10, 2023

Hi-Risk/Recurrent/Advanced PCa Video Chat, Dec 13, 2022

A heads-up – Dr. E will join us at the next meeting, Dec 19! We’ll start an hour early.

Calendar peculiarities make this our first Tuesday meeting in three weeks. The recording ends suddenly but it’s complete — the meeting came to an unexpected end when one of the moderators pushed the wrong button.

This month marks our only fundraising campaign of the year. All on the AnCan distribution already received our letter, which includes AnCan highlights of 2022. Please consider a donation based on what you’ve gotten from these recordings.

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/

Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Join our other free and drop in groups:
Men (Only) Speaking Freely …1st & 3rd Thursdays @ 8.00 pm Eastern https://www.gotomeet.me/AnswerCancer
Veterans Healthcare … 4th Thursday @ 8.00 pm Eastern https://www.gotomeet.me/AnswerCancer

Editor’s pick: Metastasis with PSA of 1 uncovered by chance. Plus a memorable quote from Dr. Antonarakis: “Don’t remember your case? Mark, we could write a movie about your case!” (bn)

Topics discussed

Marking the passing of an on-and-off participant who had his own ideas about therapy; abdominal growth tips off primary care physican to a lymph node metastasis despite PSA of 1; strategies to fill the bladder just right for radiation; scary seizure-like episode at the wheel after chemo; reread of PSMA and Axumin scans at another hospital finds previously unrecognized lesions; “Don’t remember your case? Mark, we could write a movie about your case”; good PSA response from chemo with few side effects; a seldom-made appeal for AnCan donations; low platelets puts a pause on chemo and might preclude Pluvicto later; white blood cell count still isn’t rising; pressing Orgovix maker on PPI interactions; emancipated from ADT by Dr. E; pain-free at last; concordance scan for Pluvicto patient?; ankles swelling — why?

Chat Log

Pat Martin · 6:12 PM I really appreciate your input. I will get bone scan and whole body scan tomorrow. Next week I’ll get results

Peter Kafka – MAUI · 6:36 PM I have a general question prompted by Cliff’s story. Is it routine for tissue taken from a TURP to be analyed for pathology. Might a GL-9 been seen earlier on a lower level?

Tonyfig · 6:37 PM Is there a link for Prostate Cancer Treatment Guidelines?

Carl · 6:43 PM www.pcf.org/guide/prostate-cancer-patient-guide/

AnCan- rick · 6:54 PM For NCCN PCa Guidelines, google NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(r)) Prostate Cancer Version 4.2022 – May 10, 2022 . I do not have the link , just the download.

David M · 6:59 PM Could have been dehydation?
David M · 6:59 PM dehydration

AnCan- rick · 7:52 PM https://www.foxchase.org/daniel-geynisman

Len Sierra · 7:57 PM Types of PPIs Omeprazole (Prilosec), also available over-the-counter (without a prescription) Esomeprazole (Nexium), also available over-the-counter (without a prescription) Lansoprazole (Prevacid), also available over-the-counter (without a prescription) Rabeprazole (AcipHex) Pantoprazole (Protonix)

Peter Kafka – MAUI · 7:57 PM Pantroprazole, generic name protonix

AnCan- rick · 7:58 PM Maria Calkins …. Myovant

Frank Fabish Columbus OH · 8:09 PM got to go. thanks for listening.

James Davidson (Houston) · 8:14 PM Gotta run – good evening, gents!

Mark Thompson, Rehoboth Beach, DE · 8:14 PM My thoughts and prayers are with you
Herb. Thanks again for all your help. Pain can really get to you.

Pat Martin · 8:15 PM Heading out. See you in a couple weeks

New December Art Class: Birches & Birds

Birch Trees.png
New December Art Class: Birches & Birds
Good news to fans of our art class! We’ll be painting a classic acrylic painting this December 15th at 8pm ET
If you’re able to or interested in signing up, then here’s all the info you need
It’s another BYOAS class – Bring Your Own Art Supplies
Please sign up here if you’d like to join us! All ability levels are welcome! I’ll be instructing everyone step-by-step on how to paint this. As always, feel free to add your own flair of creativity – different trees, different arrangement of trees, more birds, more branches, different colors, anything to make you love it even more 🙂
  
YOU WILL NEED:
  • Acrylic paints: Blue / Purple / Yellow / White / Brown / Black / Red (or your choice bird color)
  • Brushes: Flat 3/4in OR similar size; Round size #8 or smaller
  • Canvas: 9in x 12in (or whatever size you want!)
  • Water / napkins / paper plate or palette
 
We’ll be using a whole lot of white paint, so make sure you have plenty of that.
As for brushes, sizes are approximate. If you have something smaller, it may take a little longer (maybe!) and if you have a size a little larger, it may take a shorter amount of time (again, maybe!). 
If you have family coming in for the holidays, they’re absolutely welcome to have fun with us!!
I will send out the link to class a day or so beforehand 🙂
As always, please let me (Hannah@AnCan.org) or Alexa (Alexa@AnCan.org) know if you have any questions, comments, or suggestions. Hopefully you can join us! 
Don’t forget to sign up at the link above. Looking forward to seeing you next week!